Trademarkia Logo

Canada

C$
OXULUMIS
FORMALIZED

on 16 Apr 2025

Last Applicant/ Owned by

Regeneron Pharmaceuticals, Inc.

777 Old Saw Mill River RoadTarrytown, NY 10591

US

Serial Number

2392694 filed on 16th Apr 2025

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

OXULUMIS

Trademark usage description

combination drug delivery devices sold full containing pharmaceutical preparations for the treatment of retinal diseases; combination drug delivery d Read More

Classification Information


Class [005]
Combination drug delivery devices sold full containing pharmaceutical preparations for the treatment of retinal diseases;


Classification kind code

12

Class [010]
Combination drug delivery devices sold empty for the treatment of retinal diseases;


Classification kind code

12

Mark Details


Serial Number

2392694

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 1st May 2025
Pre-Assessment Letter Sent
Submitted for opposition 30
on 16th Apr 2025
Filed
Submitted for opposition 1
on 16th Apr 2025
Created
Submitted for opposition 31
on 16th Apr 2025
Formalized